| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie is making substantial investments in experimental treatments, with a notable commitment of up to $4.95 billion for the development of an innovative solid tumor therapy. Their focus on creating novel therapeutics, such as bispecific antibodies for advanced solid tumors, underscores a strong emphasis on product development and innovation. Additionally, the expansion of their oncology pipeline reflects strategic efforts to enhance their therapeutic offerings and market presence. These initiatives demonstrate AbbVie's determination to lead in cutting-edge medical solutions. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.1 is modestly bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.ABBV is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.9, and the negative at -0 on 2026-01-13. The forces of Sentiment towards Fundamentals (1.9), Option Sentiment (1.5), Market Risk Appetite (0.9), Price Level Sentiment (0.5), Valuation Sentiment (0.5), and Stock Price Trend (0.1) will drive up the price. The forces of and Sector Price Trend (-0.2) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 0%(0%) | 220.59 | 15 | 0.23% | -0.44% | 0.1 | -0.05% | 0.4% | 0.9 | Long | 60% | 1.9 | 5.5 |
| 2026-01-12 | 0%(0%) | 220.08 | 9 | 0% | -0.44% | -0 | -0.09% | 0.9% | 1 | Long | 75% | 1.4 | 7 |
| 2026-01-11 | 0%(0%) | -0.3 | -0.22% | 0.6 | 0.7 | -1 | |||||||
| 2026-01-10 | 0%(0%) | -0.3 | -0.22% | 0.6 | 0.5 | -1 | |||||||
| 2026-01-09 | 0%(0%) | 220.08 | 5 | -1.82% | -0.44% | -0.3 | -0.22% | 1.7% | 0.9 | Wait | 50% | 0.4 | -1 |
| 2026-01-08 | 0%(0%) | 224.17 | 31 | -3.97% | -0.22% | -0 | 0.04% | 1.4% | 0.9 | Wait | 50% | 0.4 | -5 |
| 2026-01-07 | 0%(0%) | 233.43 | 100 | 4.21% | 0.26% | 0.6 | 0.31% | 1.9% | 1.1 | Short | 88% | 1.6 | -1 |
| 2026-01-06 | 0%(0%) | 224 | 33 | 1.74% | -0.13% | -0.3 | -0.09% | 1.6% | 1.3 | Wait | 50% | 1.9 | -1 |
| 2026-01-05 | 0%(0%) | 220.18 | 0 | -4.01% | -0.13% | -0.5 | -0.22% | 2% | 1.3 | Long | 88% | 2.8 | -1 |
| 2026-01-04 | 0%(0%) | 0.1 | 0.03% | 1.2 | 2.8 | -1 | |||||||
| Long is the preferred trading strategy with 60% chance of being right. The hourly trend is almost flat and the price has reached close to the lower boundary of Bollinger band. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2026-01-13 17:51:01 The agreement between AbbVie and the Trump administration highlights a significant partnership that may influence industry practices. |
| 2026-01-13 17:51:01 AbbVie's stock rising suggests positive investor sentiment linked to the strategic deal. |
| 2026-01-13 17:51:01 The exemption from Trump Tariffs reflects the regulatory challenges faced by drugmakers and the potential financial implications. |
| 2026-01-13 17:51:01 The negotiation to cut prices indicates AbbVie's proactive approach to managing costs in response to external pressures. |
| 2026-01-13 17:03:30 The mention of AbbVie's expansion in the oncology segment indicates ongoing product development and market strategy aimed at growing its therapeutic portfolio. |
| 2026-01-13 17:03:30 Several articles report on AbbVie's stock performance and investor interest, which reflects market perceptions and confidence in the company's future prospects. |
| 2026-01-13 17:03:30 The articles discuss AbbVie's partnership with the Trump administration, which is aimed at improving access and affordability for patients, illustrating collaborative efforts in healthcare policy. |
| 2026-01-13 17:03:30 The commitment of $100 billion by AbbVie for U.S. research and development showcases the company's focus on innovation and long-term growth. |
| 2026-01-13 17:03:30 Multiple articles highlight AbbVie's agreements with the Trump administration to lower drug prices in exchange for tariff exemptions, indicating significant regulatory impacts in the pharmaceutical industry. |
| 2026-01-13 09:35:44 The positive market reaction, indicated by rising AbbVie stock, shows investor confidence in the deal and its implications for the company's future. |
| 2026-01-13 09:35:44 The exemption from tariffs granted by the Trump administration in exchange for price cuts reflects significant government influence on drug pricing. |
| 2026-01-13 09:35:44 The agreement involves AbbVie cutting some prices, raising concerns about the impact of pricing strategies in the pharmaceutical industry. |